METTL3 and neoplasm: Recent studies have revealed that patients with a high expression of METTL3 and cluster of differentiation 33+ (CD33+) myeloid‐derived suppressor cells (MDSCs) in their CC tumour tissues exhibit a marked contrast to that in adjacent tissues.41